TCM
IDYA icon

Tradewinds Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Tradewinds Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$12K – 790
2021
Q1 		$12K Hold
500
– – ﹤0.01% 421
2020
Q4 		$7K Buy
+500
New +$6.77K ﹤0.01% 476

Other funds holding IDYA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Tradewinds Capital Management's IDYA Position: Q2 2021 in Review

Tradewinds Capital Management sold out of IDEAYA Biosciences (IDYA) in Q2 2021, closing a stake of 500 shares — an estimated $12K sold.

Tradewinds Capital Management first reported a position in IDYA in Q4 2020 and held it in 2 quarters. The position peaked at $12K in Q1 2021. 84 funds tracked by Wall St. Rank hold IDYA as of Q2 2021.

  • Tradewinds Capital Management reported no remaining IDEAYA Biosciences position as of Q2 2021 after selling out during the quarter.
  • Tradewinds Capital Management sold 500 IDEAYA Biosciences shares in Q2 2021, an estimated $12K.
  • Tradewinds Capital Management first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 2 quarters.
  • Tradewinds Capital Management's IDEAYA Biosciences position peaked at $12K in Q1 2021.
  • 84 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2021.

Based on Tradewinds Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.